What SA’s first phase of COVID-19 vaccine rollout taught us

Despite the temporary suspension of the rollout of the Johnson & Johnson COVID-19 vaccine, nearly 290,000 healthcare workers have already received the jab through the Sisonke Phase 3b implementation study. Eyewitness News spoke to co-principal investigator of the Sisonke trial, Professor Glenda Gray, about the lessons learnt from the first phase of the vaccine rollout in South Africa.